These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

668 related items for PubMed ID: 19091823

  • 21. Acupuncture for irritable bowel syndrome: systematic review and meta-analysis.
    Manheimer E, Wieland LS, Cheng K, Li SM, Shen X, Berman BM, Lao L.
    Am J Gastroenterol; 2012 Jun; 107(6):835-47; quiz 848. PubMed ID: 22488079
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis.
    Sun JR, Kong CF, Qu XK, Deng C, Lou YN, Jia LQ.
    Saudi J Gastroenterol; 2020 Jun; 26(2):66-77. PubMed ID: 31898645
    [Abstract] [Full Text] [Related]

  • 23. Probiotics therapy for adults with diarrhea-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 RCTs.
    Wang Y, Chen N, Niu F, Li Y, Guo K, Shang X, E F, Yang C, Yang K, Li X.
    Int J Colorectal Dis; 2022 Nov; 37(11):2263-2276. PubMed ID: 36251040
    [Abstract] [Full Text] [Related]

  • 24. Meta-analysis of probiotics for the treatment of irritable bowel syndrome.
    McFarland LV, Dublin S.
    World J Gastroenterol; 2008 May 07; 14(17):2650-61. PubMed ID: 18461650
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R, Nikfar S, Abdollahi M.
    Clin Ther; 2008 May 07; 30(5):884-901. PubMed ID: 18555935
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome.
    Ianiro G, Eusebi LH, Black CJ, Gasbarrini A, Cammarota G, Ford AC.
    Aliment Pharmacol Ther; 2019 Aug 07; 50(3):240-248. PubMed ID: 31136009
    [Abstract] [Full Text] [Related]

  • 31. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis.
    Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P.
    Gut; 2009 Mar 07; 58(3):367-78. PubMed ID: 19001059
    [Abstract] [Full Text] [Related]

  • 32. Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study.
    Sisson G, Ayis S, Sherwood RA, Bjarnason I.
    Aliment Pharmacol Ther; 2014 Jul 07; 40(1):51-62. PubMed ID: 24815298
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The Effect of Bifidobacterium on Reducing Symptomatic Abdominal Pain in Patients with Irritable Bowel Syndrome: A Systematic Review.
    Pratt C, Campbell MD.
    Probiotics Antimicrob Proteins; 2020 Sep 07; 12(3):834-839. PubMed ID: 31741311
    [Abstract] [Full Text] [Related]

  • 35. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.
    J Clin Gastroenterol; 2012 Mar 07; 46(3):220-7. PubMed ID: 22157240
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials.
    Wu J, Lv L, Wang C.
    Front Cell Infect Microbiol; 2022 Mar 07; 12():827395. PubMed ID: 35295757
    [Abstract] [Full Text] [Related]

  • 37. Probiotics for the management of irritable bowel syndrome: a systematic review and three-level meta-analysis.
    Chen M, Yuan L, Xie CR, Wang XY, Feng SJ, Xiao XY, Zheng H.
    Int J Surg; 2023 Nov 01; 109(11):3631-3647. PubMed ID: 37565634
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis.
    Ford AC, Brandt LJ, Young C, Chey WD, Foxx-Orenstein AE, Moayyedi P.
    Am J Gastroenterol; 2009 Jul 01; 104(7):1831-43; quiz 1844. PubMed ID: 19471254
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and Safety of Probiotics, Prebiotics and Synbiotics in the Treatment of Irritable Bowel Syndrome: A systematic review and meta-analysis.
    Asha MZ, Khalil SFH.
    Sultan Qaboos Univ Med J; 2020 Feb 01; 20(1):e13-e24. PubMed ID: 32190365
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.